Skip to main content
The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 1, 2010

Articles

Biological Activities of 2-Styrylchromones
pp. 1-7(7)
Authors: Gomes, Ana; Freitas, Marisa; Fernandes, Eduarda; L.F.C. Lima, Jose

Favourites:
ADD

Gastrin: An Acid-Releasing, Proliferative and Immunomodulatory Peptide?
pp. 8-19(12)
Authors: Calatayud, Sara; Alvarez, Angeles; M. Victor, Victor

Favourites:
ADD

Current and Novel Therapies for Hepatitis B Virus Infection
pp. 20-31(12)
Authors: Sato, K.; Mori, M.

Favourites:
ADD

Latest Advancements on Serotonin and Dopamine Transporters in Lymphocytes
pp. 32-40(9)
Authors: Marazziti, Donatella; Consoli, Giorgio; Masala, Irene; Catena Dell'Osso, Mario; Baroni, Stefano

Favourites:
ADD

Lycorine and its Derivatives for Anticancer Drug Design
pp. 41-50(10)
Authors: Lamoral-Theys, D.; Decaestecker, C.; Mathieu, V.; Dubois, J.; Kornienko, A.; Kiss, R.; Evidente, A.; Pottier, L.

Favourites:
ADD
Favourites:
ADD

Knocking Down Gene Expression with Dendritic Vectors
pp. 73-86(14)
Authors: Ravina, M.; Paolicelli, P.; Seijo, B.; Sanchez, A.

Favourites:
ADD

Peptides for In Vivo Target-Specific Cancer Imaging
pp. 87-97(11)
Authors: Ferro-Flores, G.; de M. Ramirez, F.; Melendez-Alafort, L.; Santos-Cuevas, C. L.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content